Welcome to the link for my poster at the ASM 2014 Meeting.
I can be reached for more information at aswani.vijay@marshfieldclinic.org.
References to Poster presented at ASM 2014
- Abedon ST1,
Thomas-Abedon C, Thomas A, Mazure H. Bacteriophage prehistory: Is or is not
Hankin, 1896, a phage reference? Bacteriophage. 2011 May;1(3):174-178.
- Summers, C.
1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University
Press. Page 55, 64
- Summers, C. 1999 Felix d’Herelle and the Origins of
Molecular Biology. Yale University Press. Page 64
- Raettig, H.
1958. Bakteriophagie 1917 bis 1956, Teil I and II, Gustav Fischer Verlag
Stuttgart
- Raettig H.
1967. Bakteriophagie 1957 – 1965. , Gustav Fischer Verlag Stuttgart.
- Brussow H.
Phage Therapy: Quo Vadis? Clinical Infectious Diseases 2014; 58(4): 535-536
- Hankin ME.
Les microbes des riviíres de l'Inde. Ann Inst Pasteur (Paris) 1896;10:175–176.
- Twort FW. An
investigation on the nature of ultramicroscopic viruses. Lancet. 1915;2:1241–1243
- d'Hérelle F.
Sur un microbe invisible antagoniste des bacilles dysentériques. C R Acad Sci
Ser D. 1917;165:373–375.
- Summers, C.
1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University
Press. Page 82-96
- Summers, C.
1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University
Press. Page 114
- Chanishvili,
N. A Literature Review of the Practical Application of Bacteriophage
Research.Nova Biomedical Books, NY.2012. Preface.
- Summers, C.
1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University
Press. Page 125-144
- Summers, C.
1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University
Press. Page 158
[15] Abedon, ST,
Kuhl, SJ, Blasdel, BG, Kutter, EM. Phage Treatment of Human Infections.
Bacteriophage 1:2, 66-85. 2011
[16] Summers, C.
1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University
Press. Page 206
[17] Ruska H.
Über die Sichtbarmachung der bakteriophagen Lyse im Übermikroskop.
Naturwissenschaften. 1940;28:45–6. Ruska H. Über die Sichtbarmachung der
bakteriophagen Lyse im Übermikroskop. Naturwissenschaften. 1940;28:45–6.
[18] Pfankuch E,
Kausche GA. Isolierung und übermikroskopische Abbildung eines Bakteriophagen.
Naturwissenschaften. 1940;28:46.
[19] 14
[20] Sanger, F.;
Air, G. M.; Barrell, B. G.; Brown, N. L.; Coulson, A. R.; Fiddes, J. C.;
Hutchison, C. A.; Slocombe, P. M.; Smith, M. (1977). "Nucleotide sequence
of bacteriophage ΦX174 DNA". Nature 265 (5596): 687–95.
[21] Thiel K.
2004. Old dogma, new tricks—21st Century phage therapy Nature Biotechnology 22(1):
31-36. See Table 1 on page 35.
[22] Smith,
Hamilton O.; Hutchison, Clyde A.; Pfannkoch, Cynthia; Venter, J. Craig (2003).
"Generating a Synthetic Genome by Whole Genome Assembly: ΦX174
Bacteriophage from Synthetic Oligonucleotides". Proceedings of the
National Academy of Sciences 100 (26): 15440–5.
[23] Bruttin A,
Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a
safety test of phage therapy. Antimicrob Agents Chemother. 2005;49:2874–2878.
[24] Davison, WC.
1922T he bacteriolysaant Therapy of Bacillary Dysentery in Children. American
Journal of Diseases of Children 23:531-534.
[25] Spence RC,
McKinley EB. 1924. The Therapeutic Value of the Bacteriophage in Treatment of
Bacillary Dysentery. Southern Medical Journal 17 (8): 563-571
[26] Larkum, NW.
1929. Bacteriophage From a Public Health Standpoint. American Journal of Public
Health 19: 31-36
[27] Schultz, EW.
1932. Bacteriophage: possible therapeutic aid in dental infections. Journal of
Dental Research 12: 295-310.
[28] Straub, ME
and Applebaum M. 1933. Studies on commercial bacteriophage products. JAMA 100:
110-113
[29] Eaton MD and
Bayne-Jones S. 1934 Bacteriophage
therapy: review of the principles and results of the use of bacteriophage in
the treatment of infections. JAMA. 103(23):1769-1776.
[30] Eaton MD and
Bayne-Jones S. 1934 Bacteriophage
therapy: review of the principles and results of the use of bacteriophage in
the treatment of infections. JAMA103(24):1847-1853.
[31] Eaton MD and
Bayne-Jones S. 1934. Bacteriophage therapy: review of the principles and
results of the use of bacteriophage in the treatment of infections. JAMA.
103(25):1934-1939.
[32] Krueger AP
and Scribner EJ. 1941. The Bacteriophage: Its Nature and its Therapeutic Use.
JAMA 116 (19): 2160-2167.
[33] Krueger AP
and Scribner EJ. 1941. The Bacteriophage: Its Nature and its Therapeutic Use.
JAMA 116 (20): 2269-2277.
[34] Kutter, E.,
and A. Sulakvelidze. 2005. Bacteriophages: biology and applications. CRC Press,
Inc., Boca Raton, Fla. Page 396.
[35] Kutter, E.,
and A. Sulakvelidze. 2005. Bacteriophages: biology and applications. CRC Press,
Inc., Boca Raton, Fla. Page 398.
[36] Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward
LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans:
results of a phase I safety trial. J Wound Care. 2009;18:237–243